Article snapshot taken from Wikipedia with creative commons attribution-sharealike license.
Give it a read and then ask your questions in the chat.
We can research this topic together.
Revision as of 14:14, 28 January 2021editThiloZ (talk | contribs)9 edits Update on clinical data (SPARC Trial with PFS but no OS benefit, mode of action, availability (Satraplatin currently is not available), regulatory status (FDA und EMA rejected market application), more detailed description of saftey profile. Mentioning of penetration of blood brain barrier.Tags: references removed Visual edit← Previous edit
You cannot view this diff because one or both of the revisions have been removed from the public archives.
Details can be found in the deletion log for this page.